Loading clinical trials...
Loading clinical trials...
Leflunomide for the Treatment of Ambulatory Patients With Mild COVID-19
Conditions
Interventions
Leflunomide
Locations
1
United States
University of Chicago
Chicago, Illinois, United States
Start Date
May 5, 2020
Primary Completion Date
January 31, 2022
Completion Date
January 31, 2022
Last Updated
February 7, 2024
NCT06631287
NCT05101213
NCT04565665
NCT06871293
NCT04978571
NCT07221162
Lead Sponsor
University of Chicago
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions